Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TSBX Turnstone Biologics Corporation

0,4911

0,0296 (6,41%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Turnstone Biologics (NASDAQ:TSBX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Turnstone Biologics Charts.

Turnstone Biologics (NASDAQ:TSBX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Turnstone Biologics Charts.

News Turnstone Biologics Corporation

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Dienstag 12 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Dienstag 5 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 11 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Freitag 11 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 1 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 14 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 14 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Mittwoch 14 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
Mittwoch 14 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 5 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Weitere Turnstone Biologics Corporation News-Artikel

D Amico International Sh...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen